Key points from article :
Longevica is launching an end-to-end open platform to accelerate aging research and bring potential therapies to market faster.
To provide open access to all the scientific data and reduce the cost of mouse studies through Jackson Lab.
To develop and sell longevity health products directly to consumers and market.
Alexey Ryazanov, professor at Rutgers University, explored over 1000 pharmacological compounds on the lifespan of mice.
Longevica conducted an year-long analysis of all the data from the mouse study.
"...three classes of compounds showed statistically significant results,” - Abdrakhmanov, co-founder of Longevica.
Including chelators, compounds that activate detoxification machinery, and activates excretion via urine/faeces.
“When toxins and heavy metals were removed, we saw that healthspan and healthy aging improved,” - Abdrakhmanov.
Longevica platform is expected to go live in January, but it’ll be later in 2022 before all the data is fully available and collaborators are invited to join.
